Intravesical chemohyperthermia with mitomycin c for intermediate- & high-risk non-muscle invasive bladder cancer

被引：0
|
作者：
Lai, B. C. H. [1 ]
Wen, Y. -C. [1 ]
Shih, H. -J. [1 ]
机构：
[1] Taipei Municipal Wanfang Hosp, Taipei, Taiwan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
552
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [21] Management of high-risk non-muscle invasive bladder cancer
    Brausi, M.
    Olaru, V.
    [J]. MINERVA UROLOGICA E NEFROLOGICA, 2012, 64 (04) : 255 - 260
  • [22] The safety and efficacy of intravesical Mitomycin-C hyperthermia in the management of high-risk non-muscle invasive bladder cancer: A seven-year experience
    Pai, A.
    Nair, R.
    Kaul, A.
    Ayres, B.
    Bailey, M.
    Perry, M.
    Issa, R.
    [J]. BJU INTERNATIONAL, 2014, 113 : 24 - 24
  • [23] Intravesical bacillus Calmette-Guerin versus chemohyperthermia for high-risk non-muscle-invasive bladder cancer
    Ekin, Rahmi Gokhan
    Akarken, Ilker
    Zorlu, Ferruh
    Tarhan, Huseyin
    Kucuk, Ulku
    Yildirim, Zubeyde
    Divrik, Rauf Taner
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2015, 9 (5-6): : E278 - E283
  • [24] A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer
    Sousa, Alejandro
    Inman, Brant A.
    Pineiro, Idelfonso
    Monserrat, Victor
    Perez, Alberto
    Aparici, Vincente
    Gomez, Isabel
    Neira, Pilar
    Uribarri, Carlos
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2014, 30 (03) : 166 - 170
  • [25] INTRAVESICAL ADJUVANT ELECTROMOTIVE MITOMYCIN-C IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER: A RANDOMIZED CONTROLLED TRIAL
    Di Stasi, Savino Mauro
    Verri, Cristian
    Liberati, Emanuele
    Micali, Francesco
    Masedu, Francesco
    Valenti, Marco
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E674 - E674
  • [26] Biomedical markers of response to intravesical BCG treatment in high-risk non-muscle invasive bladder cancer
    Jallad, S.
    Thomas, P.
    Newport, M.
    Kern, F.
    [J]. BRITISH JOURNAL OF SURGERY, 2014, 101 : 66 - 67
  • [27] New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer
    Asimakopoulos, Anastasios D.
    Kochergin, Maxim
    Colalillo, Gaia
    Fahmy, Omar
    Hassan, Fahmy
    Renninger, Markus
    Gallioli, Andrea
    Gavrilov, Pavel
    Gakis, Georgios
    [J]. BLADDER CANCER, 2023, 9 (03) : 237 - 251
  • [28] Hyperthermic intravesical chemotherapy with mitomycin-C for the treatment of high-risk non-muscle-invasive bladder cancer patients
    Conroy, Samantha
    Pang, Karl
    Jubber, Ibrahim
    Hussain, Syed A.
    Rosario, Derek J.
    Cumberbatch, Marcus G.
    Catto, James W. F.
    Noon, Aidan P.
    [J]. BJUI COMPASS, 2023, 4 (03): : 314 - 321
  • [29] Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer
    Breyer, Benjamin N.
    Whitson, Jared M.
    Carroll, Peter R.
    Konety, Badrinath R.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2010, 28 (05) : 510 - 514
  • [30] Updates in intravesical electromotive drug administrationA® of mitomycin-C for non-muscle invasive bladder cancer
    Di Stasi, Savino Mauro
    Riedl, Claus
    [J]. WORLD JOURNAL OF UROLOGY, 2009, 27 (03) : 325 - 330
12345